Search
for
Sort by
Research 30 of 346
- Treatment of Lymphocutaneous and Visceral Sporotrichosis with Fluconazole
- Alopecia Associated with Fluconazole Therapy
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
- Alopecia Associated with Fluconazole Therapy
- Retinoic Acid Is Not Involved in Fluconazole-Induced Alopecia: Evaluation in a Human Cohort and Rat Model
- Therapeutic Potential of Secretome from Hypoxic-Mesenchymal Stem Cell (SH-MSC) in Regulating PDGF and IL-1β Gene Expression in Fluconazole-Related Alopecia
- The Effect of Topical Gel Secretome Hypoxic Mesenchymal Stem Cells (SH-MSCs) on IL-6 and TGF- β Gene Expression (Experimental Study in Male Wistar Alopecia-Like Rat Models Induced by Fluconazole)
- DESIGN AND EVALUATION OF FLUCONAZOLE LOADED ANTIDANDRUFF HAIR GEL
- Exosome Therapy from Hypoxia-treated Mesenchymal Stem Cells Reduces TNF-α and Increases VEGF Levels in Fluconazole-Induced Alopecia Model
- Secretome-Based Therapy Promotes Epidermal Thickness Recovery and Follicular Regrowth in Fluconazole-Induced Alopecia in Rats
- Secretome of Hypoxic Mesenchymal Stem Cells Improves Fluconazole-Induced Alopecia in Rats via Immunoregulatory Modulation of IL-15 and IFN-γ
- Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia)
- Alopecia Associated with Fluconazole Therapy
- The protoporphyrin IX dimethyl ester incorporated soy lecithin for photoinactivation of fluconazole-resistant Candida albicans
- A randomized, blinded, three-arm, multicenter trial comparing the efficacy and safety of fluconazole given once daily for 3 or 6 weeks with griseofulvin given once daily for 6 weeks in pediatric patients with tinea capitis
- Guidelines for the Management of Tinea Capitis in Children
- New Antifungal Agents and New Formulations Against Dermatophytes
- Novel micelle formulations to increase cutaneous bioavailability of azole antifungals
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Tinea Capitis: An Overview with Emphasis on Management
- Pediatric Tinea Capitis
- Tinea Capitis
- Therapy and Antifungal Susceptibility Profile of Microsporum canis
- Management of tinea capitis in childhood
- Treatment of tinea capitis – a critical appraisal
- A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients
- Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
- Dermatophytic Granuloma Caused by <i>Microsporum canis </i>in a Heart-Lung Recipient